News & Updates
Filter by Specialty:
Is adjunctive vitamin C beneficial to critically ill patients with COVID-19?
Use of adjunctive intravenous (IV) vitamin C for the management of critically ill patients with COVID-19 infection does not achieve the desired outcome of a reduction in the incidence of mortality, vasopressor requirements, Sequential Organ Failure Assessment (SOFA) scores, or ventilator settings, reports a study.
Is adjunctive vitamin C beneficial to critically ill patients with COVID-19?
20 Feb 2023
Social support benefits individuals prone to depression under stress
A nurturing social environment turns out to be helpful to individuals who are genetically at greater risk for developing increased depressive symptoms under adverse social conditions, as shown in a study.
Social support benefits individuals prone to depression under stress
20 Feb 2023
Fracture risk not higher with SGLT2 vs DPP4 inhibitors
The use of sodium-glucose transporter 2 (SGLT2) inhibitors among patients with diabetes does not pose an increased risk of developing fractures as compared with dipeptidyl-peptidase 4 (DPP4) inhibitors, and this is true across estimated glomerular filtration rate (eGFR) and albuminuria categories, as shown in a study.
Fracture risk not higher with SGLT2 vs DPP4 inhibitors
19 Feb 2023
Gefitinib plus chemotherapy improves survival outcomes in mutated NSCLC brain metastases
Treatment with the combination of gefitinib and chemotherapy appears to yield significant increases in progression-free survival (PFS), intracranial PFS, and overall survival in patients with untreated EGFR-mutant non-small cell lung cancer (NSCLC) brain metastases as compared gefitinib monotherapy, according to the results of the phase III GAP BRAIN study.